GEN | Insight & Intelligence™ Identifies Top 10 European Biopharma Clusters

 

First, GEN took Manhattan with the Top 10 U.S. Biopharma Clusters; now, we take Berlin with the top biopharma clusters in Europe. [© 1xpert - Fotolia.com]

First, GEN took Manhattan with the Top 10 U.S. Biopharma Clusters; now, we take Berlin with the top biopharma clusters in Europe. [© 1xpert – Fotolia.com]

GEN’s algorithm ranked the top locations that included many of the up-and-coming smaller clusters which are showing major advances. The European cluster building deploys the organizing principle of Subsidiarity, which increases the opportunity for accelerated growth. The closer the governing authority the faster decision process.

One notable example was Norway’s Oslo Cancer Cluster which will open an Innovation Park and Incubator in May 2o15. Their inclusion adds to the EU membership (now 64 members) and growing pipeline of cancer therapeutics developed through collaborations with global partners like those my firm continues to work on here in the States.

I believe we will continue to see growth in global collaborations and standardization of medical research, IP rights, research funding, Tech Transfer and commercialization.  All of which is designed to bring new discoveries to the market quicker.

To read the GEN article and see the complete list of clusters:  http://www.genengnews.com/insight-and-intelligence/top-10-european-biopharma-clusters/77900075/

 

Advertisements

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: